These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Topical corticosteroids reverse the antiviral effect of topical cidofovir in the Ad5-inoculated New Zealand rabbit ocular model. Romanowski EG; Araullo-Cruz T; Gordon YJ Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):253-7. PubMed ID: 9019458 [TBL] [Abstract][Full Text] [Related]
5. Treatment of adenoviral conjunctivitis with topical cidofovir. Gordon YJ; Naesens L; DeClercq E; Maudgal PC; Veckeneer M Cornea; 1996 Sep; 15(5):546. PubMed ID: 8862935 [No Abstract] [Full Text] [Related]
6. Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis. Clement C; Capriotti JA; Kumar M; Hobden JA; Foster TP; Bhattacharjee PS; Thompson HW; Mahmud R; Liang B; Hill JM Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):339-44. PubMed ID: 20702820 [TBL] [Abstract][Full Text] [Related]
7. A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis. Pelletier JS; Stewart K; Trattler W; Ritterband DC; Braverman S; Samson CM; Liang B; Capriotti JA Adv Ther; 2009 Aug; 26(8):776-83. PubMed ID: 19756415 [TBL] [Abstract][Full Text] [Related]
9. The effects of povidone iodine (pH 4.2) on patients with adenoviral conjunctivitis. Yazar H; Yarbag A; Balci M; Teker B; Tanyeri P J Pak Med Assoc; 2016 Aug; 66(8):968-70. PubMed ID: 27524529 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of topical immunoglobulins against experimental adenoviral ocular infection. Nwanegbo EC; Romanowski EG; Gordon YJ; Gambotto A Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4171-6. PubMed ID: 17724203 [TBL] [Abstract][Full Text] [Related]
12. Effects of diclofenac or ketorolac on the inhibitory activity of cidofovir in the Ad5/NZW rabbit model. Romanowski EG; Gordon YJ Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):158-62. PubMed ID: 11133861 [TBL] [Abstract][Full Text] [Related]
13. Povidone iodine in the treatment of adenoviral conjunctivitis in infants. Özen Tunay Z; Ozdemir O; Petricli IS Cutan Ocul Toxicol; 2015 Mar; 34(1):12-5. PubMed ID: 24678746 [TBL] [Abstract][Full Text] [Related]
14. Dexamethasone/Povidone Eye Drops versus Artificial Tears for Treatment of Presumed Viral Conjunctivitis: A Randomized Clinical Trial. Pinto RD; Lira RP; Abe RY; Zacchia RS; Felix JP; Pereira AV; Arieta CE; de Castro RS; Bonon SH Curr Eye Res; 2015 Sep; 40(9):870-7. PubMed ID: 25310347 [TBL] [Abstract][Full Text] [Related]
15. The possibility of human adenovirus detection from the conjunctiva in asymptomatic cases during nosocomial infection. Kaneko H; Maruko I; Iida T; Ohguchi T; Aoki K; Ohno S; Suzutani T Cornea; 2008 Jun; 27(5):527-30. PubMed ID: 18520499 [TBL] [Abstract][Full Text] [Related]
16. Antiviral prophylaxis with twice daily topical cidofovir protects against challenge in the adenovirus type 5/New Zealand rabbit ocular model. Romanowski EG; Yates KA; Gordon YJ Antiviral Res; 2001 Dec; 52(3):275-80. PubMed ID: 11675144 [TBL] [Abstract][Full Text] [Related]
17. Epidemic adenoviral conjunctivitis report of an outbreak in a military garrison and recommendations for its management and prevention. Majeed A; Naeem Z; Khan DA; Ayaz A J Pak Med Assoc; 2005 Jul; 55(7):273-5. PubMed ID: 16108508 [TBL] [Abstract][Full Text] [Related]
18. The role of ozonized oil and a combination of tobramycin/dexamethasone eye drops in the treatment of viral conjunctivitis: a randomized clinical trial. Cagini C; Mariniello M; Messina M; Muzi A; Balducci C; Moretti A; Levorato L; Mencacci A Int Ophthalmol; 2020 Dec; 40(12):3209-3215. PubMed ID: 32696102 [TBL] [Abstract][Full Text] [Related]
19. The in vitro and in vivo evaluation of ddC as a topical antiviral for ocular adenovirus infections. Romanowski EG; Yates KA; Gordon YJ Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5295-9. PubMed ID: 19516011 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of clinical signs, symptoms and point-of-care testing for early adenoviral conjunctivitis. Shorter ES; Whiteside MM; Harthan JS; Morettin CE; Perera CD; Johnson SD; Migneco MK; Huecker JB; Hartwick ATE; Than TP; Gordon MO Clin Exp Optom; 2022 Sep; 105(7):702-707. PubMed ID: 34751088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]